Receive filgrastim autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Pluripotent Stem Cells Bone Marrow Neural Stem Cells T-Lymphocytes Bone Marrow Cells Induced Pluripotent Stem Cells Cells, Cultured Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Spermatogonia Neoplastic Stem Cells Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases55

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Neutropenia Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Leukemia, Myeloid Leukemia Neoplasm Recurrence, Local Acute Disease Hematologic Diseases Neoplasms Hepatic Veno-Occlusive Disease Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, AIDS-Related Neuroblastoma Breast Neoplasms Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Anemia, Aplastic Mucositis Infection Lymphoproliferative Disorders Severe Combined Immunodeficiency Thrombocytopenia Fever Medulloblastoma Chromosome Aberrations Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Central Nervous System Neoplasms Postoperative Complications Disease Models, Animal Blood Group Incompatibility Paraproteinemias Chronic Disease Mycoses Roseolovirus Infections Bronchiolitis Obliterans

Chemicals and Drugs49

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Granulocyte Colony-Stimulating Factor Cytarabine Carmustine Thiotepa Vincristine Busulfan Boronic Acids Dexamethasone Pyrazines Antigens, CD34 Doxorubicin Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Thalidomide Ifosfamide Prednisone Podophyllotoxin Antineoplastic Agents Mitoxantrone Idarubicin Recombinant Proteins Immunosuppressive Agents Carboplatin Keratins, Type II Antibodies, Monoclonal Immunoglobulin Light Chains Vidarabine Cisplatin Stem Cell Factor HLA Antigens Antilymphocyte Serum Immunoconjugates Bleomycin Cyclosporine Minor Histocompatibility Antigens Methotrexate Antigens, CD Tacrolimus Antigens, CD20 Prednisolone Immunologic Factors Nitrogen Mustard Compounds Biological Markers Myeloma Proteins Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Salvage Therapy Hematopoietic Stem Cell Mobilization Disease-Free Survival Bone Marrow Transplantation Survival Rate Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Leukapheresis Prognosis Liver Transplantation Follow-Up Studies Mesenchymal Stem Cell Transplantation Blood Component Removal Induction Chemotherapy Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Histocompatibility Testing Drug Administration Schedule Prospective Studies Feasibility Studies Fatal Outcome Life Tables Radioimmunotherapy Heart Transplantation Risk Factors Lung Transplantation Immunotherapy Blood Transfusion, Autologous Organ Transplantation Transplantation, Isogeneic Lymphocyte Transfusion Clinical Trials as Topic Pilot Projects Kaplan-Meier Estimate Flow Cytometry Neoplasm Staging Platelet Count Transplantation Leukocyte Count Islets of Langerhans Transplantation Immunosuppression Treatment Failure Lymphocyte Depletion Positron-Emission Tomography Cell Separation Pancreas Transplantation Immunophenotyping Blood Cell Count Predictive Value of Tests Donor Selection Cell Culture Techniques Colony-Forming Units Assay Transplantation, Heterologous Immunomagnetic Separation Severity of Illness Index Randomized Controlled Trials as Topic Stem Cell Research Cell- and Tissue-Based Therapy Platelet Transfusion Fetal Tissue Transplantation Drug Therapy Multivariate Analysis Proportional Hazards Models Cohort Studies Leukocyte Transfusion Transplantation, Heterotopic Disease Models, Animal Infusions, Intravenous Heart-Lung Transplantation Immunotherapy, Adoptive Radiotherapy Lymphocyte Count Incidence Polymerase Chain Reaction Cell Count Reverse Transcriptase Polymerase Chain Reaction Tissue and Organ Harvesting Coculture Techniques

Psychiatry and Psychology1

Phenomena and Processes26

Graft Survival Time Factors Hematopoiesis Cell Differentiation Histocompatibility Graft vs Leukemia Effect Transplantation Immunology Dose-Response Relationship, Drug Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Platelet Count Leukocyte Count Cell Lineage Blood Cell Count Cell Proliferation Regeneration Transplantation Tolerance Immunocompromised Host Chromosome Aberrations Virus Activation Therapeutic Equivalency Cell Survival Lymphocyte Count Cell Count

Disciplines and Occupations2

Stem Cell Research Regenerative Medicine

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups5

Tissue Donors Siblings Unrelated Donors Living Donors Blood Donors

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Clinical Trials as Topic Pilot Projects Kaplan-Meier Estimate Treatment Failure Predictive Value of Tests Age Factors Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Cohort Studies Tissue and Organ Procurement Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Stem Cells Salvage Therapy Hematopoietic Stem Cell Mobilization Disease-Free Survival Etoposide Hodgkin Disease Lymphoma, Non-Hodgkin Cyclophosphamide Myeloablative Agonists Granulocyte Colony-Stimulating Factor Cytarabine Carmustine Recurrence Graft vs Host Disease Bone Marrow Transplantation Thiotepa Vincristine Survival Rate Bone Marrow Purging Hematologic Neoplasms Lymphoma, Mantle-Cell Survival Analysis Whole-Body Irradiation Retrospective Studies Hematopoietic Stem Cells Amyloidosis Busulfan Leukapheresis Boronic Acids Dexamethasone Pyrazines Antigens, CD34 Graft Survival Doxorubicin Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Prognosis Autografts Lymphoma, T-Cell, Peripheral Antineoplastic Agents, Alkylating Liver Transplantation Follow-Up Studies Thalidomide Ifosfamide Mesenchymal Stem Cell Transplantation Prednisone Lymphoma Time Factors Podophyllotoxin Blood Component Removal Transplantation Chimera Neutropenia Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Tissue Donors Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Leukemia, Myeloid, Acute Cell Transplantation Antineoplastic Agents Kidney Transplantation Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Myelodysplastic Syndromes Mitoxantrone Lymphoma, B-Cell Infusions, Spinal Leukemia, Plasma Cell Idarubicin Adult Stem Cells Neoplasms, Second Primary Recombinant Proteins Immunosuppressive Agents Histocompatibility Testing Drug Administration Schedule Prospective Studies Hematopoiesis Carboplatin Feasibility Studies Keratins, Type II Cell Differentiation Histocompatibility Antibodies, Monoclonal Mesenchymal Stromal Cells Leukemia, Myeloid Fatal Outcome Life Tables

No FAQ available that match "receive filgrastim autologous stem cell transplantation"